Why the study?
Do serum CK-MB activity and fractal dimension (FD) of heart rate variability predict death in patients with acute first-ever stroke?
Do serum CK-MB activity and fractal dimension (FD) of heart rate variability predict death in patients with acute first-ever stroke?
Increased serum CK-MB activity and decreased fractal dimension of heart rate variability in the acute phase of stroke are prognostic factors for 1-month mortality.
May inform 1-month mortality risk stratification in acute stroke; hypothesis-generating and requires prospective validation.
OBJECTIVE: To investigate the difference of heart rate variability (HRV) and serum creatine kinase isoenzyme (CK-MB) activity between right-sided and left-sided stroke, and the relative impact of cardiac autonomic imbalance and heart abnormality on death by serum CK-MB activity and fractal dimension (FD) detection in patients with stroke. METHODS: Three hundred and twenty-seven patients (mean age: 61.12 +/- 9.74 years) with an acute first-ever stroke underwent a comprehensive clinical investigation and laboratory tests, and were followed up for 1 month. Serum CK-MB activity and FD of heart rate variability were detected on the next day after admission. RESULTS: During the 1 month follow-up period, 42 out of 327 (12.84%) patients had died. Among all the variables analysed, FD decreased and serum CK-MB activity increased after stroke, and decreased FD was more common in the right-sided stroke. This study also demonstrated that acute phase increased serum CK-MB activity [odds ratio (OR)=0.226, 95% CI: 0.103-0.493, p= 0.000) and decreased FD (OR=0.276, 95% CI: 0.135-0.567, p=0.000) had been linked with the risk of death. CONCLUSIONS: Right-sided stroke and left-sided stroke had different influences on cardiac autonomic nerve activity. Acute phase increased serum CK-MB activity and decreased FD are well-established prognostic factors of death in patients with stroke. Assessment of FD and serum CK-MB activity may provide additional information on the risk of death in stroke patients.
No takes yet. Share an insight, caveat, or question.
He et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: